^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
NEXI-003
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
NexImmune
Drug class:
Survivin inhibitor, HPV-16 E6 protein inhibitor, HPV-16 E7 protein inhibitor, CD8 T-cell agonist, HPV-18 E6 protein inhibitor, HPV-18 E7 protein inhibitor
Related drugs:
Phase 1
NexImmune Inc.
Not yet recruiting
Last update posted :
01/15/2024
Initiation :
03/31/2025
Primary completion :
07/01/2026
Completion :
08/25/2027
HLA-A
|
cyclophosphamide • fludarabine IV • NEXI-003
Share
